Product Reports Resources Pricing Login Book a demo

Quantapore

Biotech & Life Sciences · Menlo Park, United States · Founded 2009

Biotech company developing nanopore-based nucleic acid sequencing technology MoreLess

Quantapore is an innovative startup focused on revolutionizing the fields of proteomics and genomics. The company is developing advanced analytical tools that can analyze proteins at the single-molecule level. These tools are designed to work in a massively parallel manner, meaning they can analyze many molecules simultaneously. This technology has the potential to significantly improve human health by providing more detailed and accurate information about proteins, which are essential for understanding diseases and developing new treatments.

Quantapore primarily serves clients in the biotechnology, pharmaceutical, and healthcare sectors. These clients include research institutions, pharmaceutical companies, and healthcare providers who need advanced tools for protein analysis to drive their research and development efforts.

The market Quantapore operates in is the life sciences sector, specifically focusing on proteomics (the study of proteins) and genomics (the study of genes). This market is rapidly growing due to increasing demand for personalized medicine, new drug development, and advanced diagnostic tools.

Quantapore's business model is based on developing and selling its proprietary protein analysis tools. The company generates revenue by selling these tools to its clients and possibly through service contracts for ongoing support and maintenance. Additionally, Quantapore may engage in partnerships or collaborations with other companies and research institutions to further develop and commercialize its technology.

In summary, Quantapore is at the forefront of developing cutting-edge protein analysis tools that have the potential to transform the life sciences industry. By serving clients in biotechnology, pharmaceuticals, and healthcare, the company is well-positioned to capitalize on the growing demand for advanced proteomics and genomics solutions.

Keywords: proteomics, genomics, protein analysis, biotechnology, pharmaceutical, healthcare, single-molecule, massively parallel, life sciences, personalized medicine.

Company overview

Quantapore company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2009
Headquarters
Menlo Park, United States
Employees
17
Open positions
None listed
Dealroom signal
23.7
sub industryBioTechnologyindustryHealthsectorBiotechnologysectorDNAsectorGenetics and genomicssectorGenome EngineeringsectorBiotech and PharmasectorHard TechsectorproteomicssectorDT and LSsectorscience-basedclient focusb2btechnologyDeep Tech

Valuation & funding

Quantapore funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jul 2018 $16M $62M Baidu Ventures · NLVC
SERIES COther financing Sep 2016 Baidu Ventures
SERIES BOther financing May 2014 $35M $140M Undisclosed
SEEDOther financing Jan 2010 $0 Undisclosed
Showing 4 recorded eventsUnlock the complete deal history →

Growth signals

Quantapore website traffic

Latest recorded traffic for Quantapore is 210 monthly website visits, down 61.8% over the last three months. Quantapore's team grew 0% over the past year.

Latest monthly visits210 3-month web change-61.8% 1-year team growth0%
Monthly website visits68 observations · Oct 2017–Sep 2025
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Quantapore compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Quantapore's talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Quantapore's cap table

Sourced from Dealroom's funding and investor records.

Series B+ 2 investors entered at this stage
Baidu Ventures
NLVC

Global footprint

Where Quantapore has talent and traffic

Workforce by country
🇺🇸 United States · Menlo Park HQ
Book a demo for the full country breakdown

In the news

Latest news about Quantapore

Recent press, funding announcements, and product moves mentioning Quantapore — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Quantapore

An AI-synthesized read of the highest-engagement posts about Quantapore on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Quantapore’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.